Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing Boundaryless: #BuildfromAnywhere, slated for February 18th and featuring executives from major healthcare companies such as Abbott Laboratories and fast-scaling startups such as Carta Healthcare. Also speaking at the conference, which is designed to help companies build, scale and manage remote software development teams, will be Darren Murph, head of remote at GitLab, a remote-first company, and Chris Herd, CEO of Firstbase, Alex Bouaziz, CEO of Deel and Job van derVoorth of Remote.com.
Carrum Health announced a partnership with Premier Spine Care to increase access to lower cost spinal surgery to employers in the Midwest. Based in the Kansas City area, Premier Spine is the first dedicated ambulatory surgery center for spine care offered by Carrum Health. The practice is rated as one of the best places to receive back and neck surgery and features two of the top orthopedic spine surgeons in the region, Dr. John M. Ciccarelli and Dr. Adrian P. Jackson.
“We are honored to partner with Carrum Health and offer our patient-focused, specialized approach to its members,” said Jackson, who is one of Premier Spine’s founders. “We take great pride in providing excellent spine care to patients, first exploring conservative treatment efforts to address pain, and then providing surgery options when needed in a state-of-the-art outpatient setting.”
Carrum Health’s Centers of Excellence SaaS platform and mobile app guides patients through all aspects of their care journey and connects them with the highest quality surgical centers. Because clinical quality is of utmost importance, Carrum Health evaluates both the COE and surgeon with a proprietary evaluation process, ensuring only the top 10% of providers are invited to join the platform.
“Our collaboration not only enables us to offer our members access to their outstanding care, but their outpatient offering promotes easier access and an excellent patient experience,” said Kristen Barlow, vice president of provider partnerships for Carrum Health.
Garner Health raised a $12 million Series A round led by Founders Fund. Maverick Ventures and Thrive Capital also took part in the round. The company provides a service for employer-provided insurance, using healthcare data to connect employers and employees with medical professionals. Founder and CEO Nick Reber previously worked at Oscar Health. Click here to read more.
Illumina has selected nine genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK.
They include five for Illumina’s San Francisco-based accelerator:
- Doloromics Inc., a pain therapeutics discovery company from Dallas, Texas, is building a proprietary platform for discovery of disease-specific pain mechanisms, biomarkers and therapeutics.
- Flightpath Biosciences, a biotechnology company from Berkeley, California, is advancing microbiome-targeted therapeutics and diagnostics for the treatment of rare infectious diseases.
- Oshun Medical Inc. is a women’s health diagnostics company from the San Francisco Bay Area working to predict pregnancy complications in women around the world.
- Parallel Health Inc. is a skin microbiome company from the San Francisco Bay Area, that aims to revolutionize skin and body care by providing deep insights and true personalization through best-in-class testing and targeted microbial formulations.
- Rubik Therapeutics, Inc. is a cancer therapeutics company from Greater Boston that’s leveraging computational biology and genome-wide screens to develop engineered cell therapies for solid tumor indications.
They also include four in its Cambridge-based accelerator:
- BiotaX Labs, a spinoff from Technion Research and Development Foundation (TRDF) Israel, is harnessing the power of the microbiome to diagnose and provide effective, tailored and safe microbial treatments.
- Broken String Biosciences, a genomics company from Cardiff, UK, is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation of innovative medicines, including cell and gene therapies.
- Mitra Bio, a skin longevity company from London, is building a non-invasive skin multi-omics platform to unravel skin health and delay ageing.
- MultiplAI Health, a diagnostics company from London and Buenos Aires, Argentina, is leveraging advances in genomics and artificial intelligence to develop universal remote screening for cardiovascular diseases.
